Pharmaceutical manufacturer for Ciprofloxacin

Dr. Reddy’s Laboratories Ltd. functions as an integrated pharmaceutical firm, dedicated to supplying cost-effective and innovative medications to promote healthier lifestyles. With a focus on Pharmaceutical Services & Active Ingredients, Global Generics, and Proprietary Products, Dr. Reddy’s delivers a range of products and services such as APIs, customized pharmaceutical services, generics, biosimilars, and distinct formulations. The primary therapeutic areas of concentration encompass gastro-intestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Dr. Reddy’s has a presence in various global markets, with significant engagements in the USA, Europe, India, Russia, and other CIS nations.

Wockhardt UK (WUK) operates as a diverse pharmaceutical company, serving as a significant provider of healthcare products to the NHS through hospitals, multiple retail pharmacy chains, and wholesalers. It is currently experiencing an exciting period with thriving export and contract manufacturing divisions. Leveraging the global strength, research base, and impressive product pipeline of its parent company, Wockhardt UK is well-positioned for future growth.

Established in 1984, Neuland Laboratories Limited is a publicly traded company based in Hyderabad, India. The organization offers solutions throughout the entire range of the pharmaceutical industry's chemical needs, from synthesizing library compounds to providing NCEs and advanced intermediates at different stages in the clinical life cycle, as well as for commercial launch. Neuland's specialty lies in the production of APIs and advanced intermediates from its facilities approved by the USFDA. Its primary expertise is the application of effective process chemistry to manufacturing in a compliant regulatory setting.

Aarti Drugs Ltd (ADL) is a part of the Aarti Group of Industries, which has a total worth of USD 500 million. It was established in 1984 and has since developed a strong presence in the fields of Anti-diarrhea and Anti-inflammatory therapeutic groups. The company's manufacturing facilities are located in Tarapur and Sarigam, where it produces a variety of medicines including Vitamins, Anti-arthritis, Anti-fungal, Antibiotics, ACE inhibitors, anti-diabetic, anti-cholinergic, sedatives, and anti-depressant drugs. Over the years, ADL has successfully carved a niche for itself and is now planning to increase its production capacity.

Indoco Remedies Limited, based in India, is an emerging, fully integrated, research-oriented pharmaceutical firm with a global presence. We manufacture a diverse range of cost-effective, high-quality products in various therapeutic sectors that are widely embraced by healthcare professionals and clients across the globe. The company boasts a robust production infrastructure, a focus on Research & Development, and is uniquely positioned as a preferred collaborator providing comprehensive solutions to pharmaceutical companies marketing generics

Bringing 86 years of expertise, UQUIFA'S operational approach is built on a fusion of a high-quality production platform and a proven history of service and dependability. UQUIFA specializes in the production of Active Pharmaceutical Ingredients (APIs), Intermediates, and RSM's for the pharmaceutical and animal health sectors on a global scale. The organization runs 2 production facilities (located in Spain and Mexico) with stringent compliance to all regulatory standards. These facilities operate under cGMP conditions and have undergone evaluation and endorsement from prominent global pharmaceutical companies.

HELM AG, a company based in Hamburg and owned by a family, has a 120-year history in 4 diverse sectors: Pharmaceuticals, Chemicals, Crop Protection, and Crop Nutrition. With a global presence through subsidiaries, sales offices, and partnerships, HELM is recognized as one of the world's leading independent marketing firms for chemicals. At HELM Pharma, our goal is to establish ourselves as the top B2B project and marketing platform, offering a distinctive partnership experience. In the marketing of our products, we deliver a comprehensive range of services for our business associates.

Smruthi Organics Ltd operates as an active pharmaceutical ingredient (API) manufacturing firm located in the country of India. With more than three decades of experience, we have been providing API to pharmaceutical firms worldwide. Our commitment to delivering top-notch API at competitive prices and within the set timelines has solidified our position as a key manufacturer of anti-diabetes, anti-hypertension, anti-platelet, and anti-infective API in India. Additionally, our API manufacturing facility holds GMP certification. Our proficient team of QA & Regulatory Affairs experts extends unparalleled technical and documentation support globally. Furthermore, we are publicly listed on the Bombay Stock Exchange (BSE).

DONGBANG FTL originated under the name Dongbang Synthetic Chemical with the aim of becoming the most well-known and reliable company in the active ingredients sector through honest competition

Zhejiang Jingxin Pharmaceutical Co., Ltd. was established in 1990. It is a listed pharmaceutical company integrating R&D, production and sales. Following the business policy of "strengthening the main business of pharmaceuticals and developing medical devices", adhering to the core values ​​of "pragmatism, innovation, tolerance and win-win", and taking "carefully protecting health" as its mission, it is committed to becoming a leader in the fields of Chinese psychiatric, neurological, cardiovascular and cerebrovascular diseases...

Founded in October 2000, Zhejiang Guobang Pharmaceutical is a core enterprise of the Guobang Pharmaceutical Group. The company is located in the Hangzhou Bay Shangyu Economic and Technological Development Zone in Shangyu District, Shaoxing, Zhejiang Province, lying between the provincial capital of Hangzhou and the coastal city of Ningbo, in the hinterlands of the Yangtze River Delta economic region. It is well-connected to the transport network, with two sea bridges leading straight to Shanghai, as well as easy access to an airport, the high-speed rail, expressways, national highways, canals and ports. The company's core is in pharmaceutical manufacturing technology and it is engaged in the R&D, production, and operation for pharmaceutical and veterinary APIs and is a well-established manufacturer of synthetic APIs in China. The company's primary products are quinolones and macrolides and it is the world's leading producer of azithromycin, clarithromycin, roxithromycin, ciprofloxacin, enrofloxacin and marbofloxacin. Its production capacity and market share are above 35% in both the Chinese and international markets and its products are exported to 112 countries and regions, covering 6.5 billion people. Its sales network covers all regions of China and the US and European markets. The company is a national high-tech enterprise, with a national-level postdoctoral research station, a province-level pharmaceutical research institute, and a province-level enterprise technology center. It has received National Production Safety Standardization Certification, ISO 9001：2008 quality management certification and ISO 14001 environmental management system certification. All products have received national pharmaceutical and veterinary GMP certification, and all main products have received EUGMP, FDA, PMDA, ANVISA, MFDS and other certifications.

Ever since its establishment in 2000, Pharmacostech has played a prominent role in the fine chemical industry. The company has cultivated fundamental technologies, optimized manufacturing processes, and harnessed new discoveries from both internal and external laboratories. This includes the synthesis of novel chemicals and the development of environmentally-friendly processes, which have been successfully commercialized. In 2005, they commissioned a state-of-the-art GMP factory in Hwaseong, Gyeonggido, building upon their advanced technology. Today, Pharmacostech is embarking on its next challenge as a leading API producer.

At Shiono Finesse, we contribute to the global community through our fine chemicals business, focusing on the research and production of pharmaceutical products. Our commitment to our employees and society is to consistently and dependably create exceptional products of assured quality, while prioritizing safety and a worldwide environmental awareness.

Kores India Limited, Pharmaceuticals & Chemicals Division, is a top producer of APIs and Pharmaceutical Intermediates

Akzo Nobel India produces and markets a diverse range of coatings and specialized chemicals. About 1,780 individuals are employed in the six manufacturing plants, two advanced research labs, and 75 storage facilities throughout India; its network of retailers amounts to an impressive 8500 and continues to expand. The company attracts some of the finest talent in the nation, with the ANI workforce consisting of dedicated and highly motivated individuals.

Ildong Hyaltech Co., Ltd. is dedicated to global leadership and development with clients by delivering unparalleled excellence and knowledge. The company specializes in producing hyaluronic acid for use in pharmaceuticals, medical instruments, and beauty products. Its manufacturing facility has obtained GMP certification for both raw medicinal ingredients and medical instruments, and fully adheres to all applicable domestic and international statutes and standards to guarantee the production of top-quality goods. The facility also rigorously manages aseptic preparations using advanced technology.